GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Other Income (Expense)

Willow Biosciences (Willow Biosciences) Other Income (Expense) : $0.24 Mil (TTM As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Willow Biosciences Other Income (Expense)?

Willow Biosciences's other income expense for the Willow Biosciences's pretax income for the three months ended in Dec. 2023 was $0.25 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was $0.24 Mil.

Willow Biosciences Other Income (Expense) Historical Data

The historical data trend for Willow Biosciences's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Willow Biosciences Other Income (Expense) Chart

Willow Biosciences Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.16 -13.44 13.01 2.48 0.24

Willow Biosciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 -0.01 - - 0.25

Willow Biosciences Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Willow Biosciences  (OTCPK:CANSF) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Willow Biosciences (Willow Biosciences) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Willow Biosciences Inc (OTCPK:CANSF) » Definitions » Other Income (Expense)
Comparable Companies
TSX:VPH TSXV:HASH TSXV:DHB XCNQ:XTRX XCNQ:RVV NEOE:FH XCNQ:IMCC TSXV:MPH TSXV:CANB TSXV:NDVA ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
3D7:Germany WLLW:Canada
Address
202, 1201 5th Street SW, Calgary, AB, CAN, T2R 0Y6
Website
https://www.willowbio.com
Willow Biosciences Inc is a Canadian biotechnology company. It has only one reportable segment engaged in developing and producing high-purity, plant-derived ingredients for consumer care, food and beverage, and pharmaceutical products. Geographically, it derives a majority of its revenue from Canada.